New record of preclinical diagnosis of American visceral leishmaniasis in Amazonian Brazil encourages optimizing disease control

xmlui.dri2xhtml.METS-1.0.item-date
2020xmlui.dri2xhtml.METS-1.0.item-files-viewOpen
xmlui.mirage2.itemSummaryView.MetaData
xmlui.ArtifactBrowser.ItemViewer.show_fullxmlui.dri2xhtml.METS-1.0.item-uri
http://patua.iec.gov.br//handle/iec/4092xmlui.dri2xhtml.METS-1.0.item-author
Lima, Luciana
Santos, Thiago Vasconcelos dos
Campos, Marliane Batista
Ramos, Patrícia Karla
Gomes, Claudia Maria de Castro
Laurenti, Marcia
Matta, Vania da
Corbett, Carlos Eduardo Pereira
Silveira, Fernando Tobias
xmlui.dri2xhtml.METS-1.0.item-abstract
The clinical-immunological spectrum of human Leishmania (L.) infantum chagasi-infection in Amazonian Brazil has recently been reviewed based on the combined use of the delayed-type hypersensitivity (DTH) and indirect fluorescence antibody test (IFAT-IgG/IgM), both with homologous L. (L.) infantum chagasi-antigens, and associated with the clinical evaluation of infected individuals. This diagnostic approach has allowed to identify the broadest clinical-immunological spectrum of human L. (L.) infantum chagasi-infection composed by five clinical-immunological profiles of infection: three asymptomatic, 1) Asymptomatic Infection (AI) [DTH+/++++, IFAT−], 2) Subclinical Resistant Infection (SRI) [DTH+/++++, IFAT+/++], and 3) Indeterminate Initial Infection (III) [DTH−, IFAT+/++], and two symptomatic ones, 4) Symptomatic Infection (SI) [=American visceral leishmaniasis - AVL] and, 5) Subclinical Oligosymptomatic Infection (SOI), both with the same immune profile [DTH−, IFAT+++/++++]. Herein, we confirm for the third time the preclinical diagnosis of AVL through IgM-antibody response in an early asymptomatic case of infection (profile III), a 17-year-old boy who evolved to AVL (=profile SI) six weeks after the initial infection diagnosis, confirming that the combined use of DTH and IFAT-(IgG/IgM) assays associated with the clinical evaluation of infected individuals is potentially useful for monitoring human L. (L.) infantum chagasi-infection in endemic areas as well as optimizing AVL control.
xmlui.dri2xhtml.METS-1.0.item-citation
LIMA, Luciana et al. New record of preclinical diagnosis of American visceral leishmaniasis in Amazonian Brazil encourages optimizing disease control. Parasite Epidemiology and Control, v. 10, e00154, p. 1-6, Aug. 2020.xmlui.dri2xhtml.METS-1.0.item-decsPrimary
Leishmaniose Visceral / patologiaLeishmaniose Visceral / parasitologia
Leishmaniose Visceral / diagnóstico
Controle de Doenças Transmissíveis